abstract |
Embodiments of the present invention relate to compounds having physiological effects such as activation of hematopoietic growth factor receptors. Embodiments of the invention also relate to the use of the above compounds to treat a variety of conditions, diseases and conditions such as hematopoietic conditions and disorders. |